The European Union's drugs regulator said on Friday it concluded a review into the safety of Eisai and Biogen's Alzheimer's ...

European Union's human medicines committee (CHMP) said on Friday it is not updating its opinion on Eisai and Biogen's ...

Dr. Solomon Carter Fuller was the first Black psychiatrist and neurologist in the United States but has long been overlooked.

The latest genome-wide study spanning multiple ancestries offers promising advancements in predicting Alzheimer’s disease ...

Myra Solano Garcia, who has Alzheimer's, says the drug Kisunla may be one reason she can still drive, cook, and sing.

Air pollution contributes to nearly 7 million premature deaths each year, and its effects go far beyond the lungs.

Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...

Daughters Against Alzheimer's is proving to be a formidable foe against the debilitating disease. The nonprofit announced it ...

Alzheimer’s Disease patients and their families spent Wednesday at the state capitol complex in Hartford. They are meeting ...

Alzheimer’s Association’s advocacy day highlights push for the bills that are pending on Beacon Hill. One measure would require more training for emergency workers who deal with Alzheimer’s patients.

Owner of Sterling Heights, Rochester and Pontiac locations talks about Visiting Angels successful support of the Alzheimer’s ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP) ...